Cortexyme reports third quarter results

Cortexyme announces third quarter 2019 financial results and provides business update.q3 loss per share $0.37.q3 earnings per share estimate $-0.37 -- refinitiv ibes data.cash, cash equivalents, and short and long-term marketable securities as of september 30, 2019, were $127.8 million.cortexyme - expects current cash, cash equivalents and marketable securities sufficient to fund its operating and capital expenditures through 2021.
QNCX Ratings Summary
QNCX Quant Ranking